Alembic Pharma announces USFDA final approval for Icatibant injection, 30 mg/3 mL (10 mg/mL)… EP News Bureau Jun 17, 2024 The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Firazyr Injection, 30 mg/3 mL (10…
Glenmark gets US FDA nod for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled… EP News Bureau May 24, 2021 This marks Glenmark’s first synthetic decapeptide injectable approval and will be manufactured in their North American…
